- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Shanghai JunTop Biosciences Co., LTD
Total 1186 results
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Urothelial CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Terminated
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.CompletedNasopharyngeal Carcinoma | Head and Neck Squamous Cell CarcinomChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingResectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Terminated
-
Mabwell (Shanghai) Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedAdvanced or Metastatic Solid TumorsChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.CompletedModerate to Severe PsoriasisChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal Carcinoma | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.UnknownMelanoma | Urological CancerChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Malignant Solid TumorChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingPulmonary Fibrosis | TumorAustralia
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingAdvanced Pancreatic CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingPrimary Hypercholesterolaemia and Mixed DyslipidemiaChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingSolid Tumors
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingIntrahepatic CholangiocarcinomaChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingGastric or Esophagogastric Junction AdenocarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingPatients With Advanced Solid TumorsChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingMelanoma | Breast Cancer | Lung CanceChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.CompletedAsthma | Atopic Dermatitis | COPDChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)China, Singapore
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingStage II-III Non-small Cell Lung CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingPrimary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1China